From a molecular perspective, we sought to assess how these agents influence the cellular mechanisms associated with immune regulation and cancer cell survival, specifically through the modulation of FOXP3, a key transcription factor involved in immune suppression. The gene discussed is FOXP3; the disease is cancer.